Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing

Grants

Funding Acknowledgements

Authors Louisa Degenhardt, Richard P. Mattick and Briony Larance received funding to conduct post-marketing surveillance of the diversion and injection of buprenorphine-naloxone, 2006-2008, via an untied educational grant from Reckitt Benckiser; the Company had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the conception of, or decision to submit, this paper for publication.